CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
Ji Young Choi, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Seong Jin Jo
Cancer Research and Treatment. 2019;51(1):169-177.   Published online 2018 April 5    DOI: https://doi.org/10.4143/crt.2017.491

Excel Download

The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
Cancer Research and Treatment. 2019;51(1):169-177   Crossref logo
Link1 Link2 Link3

Monoclonal Antibodies Versus Tyrosine Kinase Inhibitors Concurrent with Chemotherapy in Non–Small-Cell Lung Cancer: Exploring Divergent Results
Clinical Lung Cancer. 2008;9(3):141-143   Crossref logo
Link1 Link2

Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis
Medical Oncology. 2015;32(2):   Crossref logo
Link1 Link2 Link3

P2-048: Activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in chemotherapy-pretreated non-small cell lung cancer (NSCLC) patients (pts) prospectively selected according to specific molecular predictive factors
Journal of Thoracic Oncology. 2007;2(8):S509   Crossref logo
Link1 Link2

Chemotherapy of advanced non-small-cell lung cancer: A randomized trial of three cis-platin-based chemotherapy regimens
Lung Cancer. 1990;6(1-2):58   Crossref logo
Link1 Link2

408P Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutation
Annals of Oncology. 2020;31:S1402   Crossref logo
Link1 Link2

Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors
Radiology and Oncology. 2017;51(3):241-251   Crossref logo
Link1 Link2

Comparison of alternating to nonalternating chemotherapy regimens for non-small cell lung cancer
Lung Cancer. 1987;3(1):50   Crossref logo
Link1 Link2

EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
Scientific Reports. 2016;6(1):   Crossref logo
Link1 Link2 Link3

A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer
Lung Cancer. 1995;13(3):350   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.